Thromboembolism after negative TEE

Comment

W J Manning et al. Circulation. 1994 Dec.

. 1994 Dec;90(6):3121-2.

doi: 10.1161/01.cir.90.6.3121.

No abstract available

Comment on

Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study.
Black IW, Fatkin D, Sagar KB, Khandheria BK, Leung DY, Galloway JM, Feneley MP, Walsh WF, Grimm RA, Stollberger C, et al. Black IW, et al. Circulation. 1994 Jun;89(6):2509-13. doi: 10.1161/01.cir.89.6.2509. Circulation. 1994. PMID: 8205657 Clinical Trial.

Is it safe to cardiovert atrial fibrillation without anticoagulation if the transoesophageal echocardiogram is normal?
Chambers J. Chambers J. Int J Cardiol. 1998 Jan 31;63(2):107-9. doi: 10.1016/s0167-5273(97)00277-5. Int J Cardiol. 1998. PMID: 9510482
Cardioversion related thromboembolism: value of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.
Seidl K, Senges J. Seidl K, et al. Card Electrophysiol Rev. 2003 Dec;7(4):392-6. doi: 10.1023/B:CEPR.0000023147.52620.85. Card Electrophysiol Rev. 2003. PMID: 15071262 Review.
Patients undergoing cardioversion of atrial flutter should be routinely anticoagulated.
Densèm CG. Densèm CG. Am J Cardiol. 1999 Jan 1;83(1):140-1. Am J Cardiol. 1999. PMID: 10073808 No abstract available.
Transesophageal echocardiography during cardioversion of atrial fibrillation.
Omran H, Lüderitz B. Omran H, et al. Am J Cardiol. 2001 Jan 1;87(1):126. doi: 10.1016/s0002-9149(00)01420-x. Am J Cardiol. 2001. PMID: 11202314 No abstract available.
Low-molecular-weight heparin in transesophageal echocardiography-guided cardioversion of atrial fibrillation.
Wodlinger AM, Pieper JA. Wodlinger AM, et al. Pharmacotherapy. 2003 Jan;23(1):57-63. doi: 10.1592/phco.23.1.57.31917. Pharmacotherapy. 2003. PMID: 12523460 Review.